QHSLab 2023 revenue up 13% to $1.41M; net loss halved to $(240K)

QHSLab, Inc.

Revenue of $1,408,995, up from $1,243,186 in 2022, driven by allergy kits and digital medicine subscriptions.
Gross margin improved to 56.3% from 49.8%; gross profit $793,607.
Net operating loss reduced to $(240,158) from $(560,539); sales & marketing down to $488,537.
New EHR partnership connects 160,000 medical professionals; evidence-based PHQ-9/GAD-7 improvements shown.
R&D spending increased slightly to $214,008 for proprietary platform enhancements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.